Joseph Geraci

Joseph Geraci is a highly accomplished professional with extensive experience in technology and science within the pharmaceutical and healthcare sectors. Currently serving as Chief Technology Officer and Chief Scientific Officer at NetraMark and Nurosene, Joseph has a proven track record of driving innovation through artificial intelligence and data science. Previous roles include data scientist at Equifax Canada, project scientist at CAMH, and machine learning lead at TORONTO EAST GENERAL HOSPITAL, among others. Joseph holds multiple advanced degrees, including PhDs in Mathematical Physics and Applied Mathematics from the University of Southern California and the University of Toronto, respectively, and has contributed significantly to areas like personalized medicine and drug discovery through advanced machine learning and bioinformatics.